Myelodysplastic changes in three cases within 100 days after allogeneic bone marrow transplantation

International Journal of Hematology

Volumn 63, Issue 2, 1996, Pages 155-160

  Okamoto, Takahiro ^a   Kanamaru, Akihisa ^a   Okada, Masaya ^a   Kawaguchi, Kohtarou ^a   Saheki, Kaname ^a   Takatsuka, Hiroyuki ^a   Fujimori, Yoshihiro ^a   Takemoto, Yoshinobu ^a   Kohsaki, Masatoshi ^a   Kakishita, Eizo ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

allogeneic bone marrow transplantation; ineffective erythropoiesis; myelodysplastic changes

Indexed keywords

CYCLOSPORIN; GANCICLOVIR; METHYLPREDNISOLONE; RECOMBINANT ERYTHROPOIETIN; TACROLIMUS;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; DRUG COMBINATION; DRUG THERAPY; ERYTHROPOIESIS; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORPHOLOGY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 13344284654     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-5710(95)00429-7     Document Type: Article

References (12)

1. Thomas ED, Storb R, Clift RA et al. Bone-marrow transplantation. N Engl J Med 1975;292:832-843.
2. Bilgrami GD, Almeida JJ, Quinn D et al. Pancytopenia in allogeneic marrow transplant recipients: role of cytomegalovirus. Br J Haematol 1994;87:357-362.
3. Apperley JF, Dowding C, Hibbin J et al. The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp Hematol 1989;17:38-45.
4. Simmons P, Kaushansky K, Trok-Storb B. Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci USA 1990;87: 1386-1390.
5. Antin JH, Ferrara JLM. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992;80:2964-2968.
6. Atkinson K, Downs K, Golenia M et al. Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection. Br J Haematol 1991;79:57-62.
7. Kojima S, Tsuchida M, Matsuyama T. Myelodysplasia and leukemia after treatment of aplastic anemia with G-CSF. N Engl J Med 1992;326:1294-1295.
8. Imashuku S, Hibi S, Kataoka-Morimoto Y et al. Myelodysplasia and acute myeloid leukemia in cases of aplastic anaemia and congenital neutropenia following G-CSF administration. Br J Haematol 1995;89:188-190.
9. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994;14:495-504.
10. Kanamaru A, Takemoto Y, Kakishita E et al. FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressant. Bone Marrow Transplant 1995; 15:885-889.
11. Chan T, Juneja S, Wolf M, Januszewicz E, Cooper I. Secondary myelodysplastic syndrome following bone marrow transplantation: report of two cases. Bone Marrow Transplant 1994;13:145-148.
12. Stone RM, Neuberg D, Soiffer R et al. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1994;12:2535-2542.